Article Details
Retrieved on: 2022-02-14 20:47:50
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
2B: The Impact of Updated Sub-Analysis Data on the Role of Larotrectinib for NTRK Fusion-Positive Thyroid Cancer. February 14, 2022.
Article found on: www.targetedonc.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here